These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36916720)

  • 1. Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus.
    Tang TS; Liao F; Webber D; Gold N; Cao J; Dominguez D; Gladman D; Knight A; Levy DM; Ng L; Paterson AD; Touma Z; Urowitz MB; Wither J; Silverman ED; Pullenayegum EM; Hiraki LT
    Rheumatology (Oxford); 2023 Nov; 62(11):3749-3756. PubMed ID: 36916720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE.
    Webber D; Cao J; Dominguez D; Gladman DD; Levy DM; Ng L; Paterson AD; Touma Z; Urowitz MB; Wither JE; Silverman ED; Hiraki LT
    Rheumatology (Oxford); 2020 Jan; 59(1):90-98. PubMed ID: 31236574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study.
    Pokroy-Shapira E; Gelernter I; Molad Y
    Clin Rheumatol; 2014 May; 33(5):649-57. PubMed ID: 24535410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort.
    Chen YJ; Hsiao TH; Lin YC; Jeng WJ; Mao CL; Wei CY; Hsieh YC; Huang CJ; Pan MH; Chen IC; Lin CH; Chen YM; Yang HI
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38637112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.
    Bastian HM; Roseman JM; McGwin G; Alarcón GS; Friedman AW; Fessler BJ; Baethge BA; Reveille JD;
    Lupus; 2002; 11(3):152-60. PubMed ID: 12004788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis and renal disease involvement in patients with systemic lupus erythematosus: a cross-sectional cohort study.
    Hermansen ML; Sandholt B; Fuchs A; Sillesen H; Køber L; Kofoed KF; Faurschou M; Jacobsen S
    Rheumatology (Oxford); 2018 Nov; 57(11):1964-1971. PubMed ID: 30016488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
    Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.
    Reppe Moe SE; Molberg Ø; Strøm EH; Lerang K
    Lupus; 2019 Jun; 28(7):818-825. PubMed ID: 31072277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
    Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study.
    Karlsson L; Zickert A; Svenungsson E; Schmidt-Mende J; Faustini F; Gunnarsson I
    Clin Rheumatol; 2023 Nov; 42(11):2981-2986. PubMed ID: 37439924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study.
    Smith EMD; Yin P; Jorgensen AL; Beresford MW;
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):14. PubMed ID: 29467038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
    Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
    Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus.
    Wang Y; Yu X; Xie X; Li H; Yang W; Liang Y; Lu W
    Ren Fail; 2023 Dec; 45(1):2235431. PubMed ID: 37470370
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk and Factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients.
    Chan SCW; Wang YF; Yap DYH; Chan TM; Lau YL; Lee PPW; Lai WM; Ying SKY; Tse NKC; Leung AMH; Mok CC; Lee KL; Li TWL; Tsang HHL; Yeung WWY; Ho CTK; Wong RWS; Yang W; Lau CS; Li PH
    Front Immunol; 2023; 14():1200732. PubMed ID: 37398664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of osteonecrosis in children and adults with systemic lupus erythematosus.
    Webber D; Cao J; Dominguez D; Gladman DD; Knight A; Levy DM; Liao F; Ng L; Paterson AD; Touma Z; Wither J; Urowitz M; Silverman ED; Hiraki LT
    Rheumatology (Oxford); 2023 Sep; 62(9):3205-3212. PubMed ID: 36651668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.
    Atkinson MA; Joo S; Sule S
    PLoS One; 2019; 14(3):e0214248. PubMed ID: 30925172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of clinical and pathomorphological features of lupus nephritis in children.
    Szymanik-Grzelak H; Barabasz M; Wikiera-Magott I; Banaszak B; Wieczorkiewicz-Płaza A; Bieniaś B; Drożynska-Duklas M; Tkaczyk M; Pańczyk-Tomaszewska M
    Adv Med Sci; 2021 Mar; 66(1):128-137. PubMed ID: 33545446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.